Tonix Pharmaceuticals
TNXP
TNXP
81 hedge funds and large institutions have $67M invested in Tonix Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 31 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
14% more capital invested
Capital invested by funds: $58.5M → $67M (+$8.48M)
4.54% more ownership
Funds ownership: 31.78% → 36.32% (+4.5%)
Holders
81
Holding in Top 10
–
Calls
$2.36M
Puts
$1.85M
Top Buyers
| 1 | +$7.22M | |
| 2 | +$3.03M | |
| 3 | +$2.17M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.16M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.97M |
Top Sellers
| 1 | -$7.61M | |
| 2 | -$1.41M | |
| 3 | -$1.15M | |
| 4 |
Jane Street
New York
|
-$471K |
| 5 |
Morgan Stanley
New York
|
-$381K |
